Core Scientific, Inc. reported $440M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $440M (to Q2 2026). Net income: −$1.43B, trailing twelve months to Q2 2026. Free cash flow: −$958M, trailing twelve months to Q2 2026. Operating margin: −133%, trailing twelve months to Q2 2026.

CORZCore Scientific, Inc.

Technology

$15.42-7.2% 1Y

$15.42

$13.5752 weeks$29.16

CORZ as reported

Core Scientific, Inc. reported $440M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed.

$440M

Revenue, trailing twelve months · to Q2 2026 · +26% against the twelve months before

Net income: −$1.43B
Net income · +29% year on year · trailing twelve months to Q2 2026
Free cash flow: −$958M
Free cash flow · +273% year on year · trailing twelve months to Q2 2026
Operating margin: −133%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CORZ, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$440M	+26%	Q2 2026
Net income	−$1.43B	+29%	Q2 2026
EPS	−$4.23	+541%	Q2 2026
Gross margin	25%	n/a	Q2 2026
Operating margin	−133%	n/a	Q2 2026
Net margin	−228%	n/a	Q2 2026
ROE	61%	n/a	Q2 2026
ROA	−29%	n/a	Q2 2026
ROIC	8.5%	n/a	Q1 2025 · 5 quarters behind
Free cash flow	−$958M	+273%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.